To study the effect of Deuterium depleted water in patients receiving neoadjuvant chemotherapy (NACT) for triple negative (TNBC) or HER2 positive breast cancer
Phase 2
- Conditions
- Health Condition 1: C50- Malignant neoplasm of breast
- Registration Number
- CTRI/2024/06/068676
- Lead Sponsor
- Tata Memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All individuals above 18 years of age having histopathologicaly proven,
triple negative breast cancer (mTNBC) or Her-2 positive breast cancer who
are going to receive neo-adjuvant chemotherapy.
2. Has a performance status of 0-3 on the Eastern Cooperative Oncology
Group (ECOG) Performance Scale.
3. Willing and able to provide written informed consent and able to comply with
all trial procedures.
Exclusion Criteria
1. Patients who do not have histopathologicaly proven triple negative breast
cancer (mTNBC) or Her-2 positive breast cancer
2. Patients who are not eligible for neo-adjuvant chemotherapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method